User login
CHEST Annual Meeting Highlights 2017
Article Type
Changed
- Sepsis response team not beneficial
- Outcomes better for patients with H1N1 vaccination
- Lung recovery high after ECMO in near-fatal asthma
- Robotic-assisted pulmonary lobectomy removes large tumors
- Aspirin responsiveness improved in some with obstructive sleep apnea
- Solriamfetol improves excessive sleepiness in OSA patients
- Acute kidney injury linked with doubled inpatient VTEs
- Alarm reductions don’t improve ICU response times
- ARDS incidence is declining. Is it a preventable syndrome?
- Balanced crystalloids protect kidney better than saline
- Omalizumab helps asthma COPD overlap patients
- Nebulized glycopyrrolate improves lung function in COPD
- Nebulized LABA safe for long-term use in COPD
- IGRA preferred test for latent TB diagnosis
- Only half of appropriate COPD patients get long-acting bronchodilators
- Rapid influenza test obviates empiric antivirals
- Remimazolam surpasses midazolam
- Revised guidelines raise lung cancer screening age ceiling
- Ultrathin bronchoscopy plus radial EBUS unreliable at making diagnoses
- Phrenic-nerve stimulator maintains benefits for 18 months
- Cardiogenic shock boosts PAH readmissions 10-fold
- Evidence mounts for pulmonary embolism benefit from catheter thrombolysis
- Tracheobronchial tree size changes may predict IPF outcomes
- Shorter walk test predicts IPF outcomes
- Comparing arterial ratios may aid risk assessment in IPF
- FDA’s standards for approving generics are questioned
- Live Streaming at CHEST 2017
Meeting/Event
Publications
Sections
Meeting/Event
Meeting/Event
- Sepsis response team not beneficial
- Outcomes better for patients with H1N1 vaccination
- Lung recovery high after ECMO in near-fatal asthma
- Robotic-assisted pulmonary lobectomy removes large tumors
- Aspirin responsiveness improved in some with obstructive sleep apnea
- Solriamfetol improves excessive sleepiness in OSA patients
- Acute kidney injury linked with doubled inpatient VTEs
- Alarm reductions don’t improve ICU response times
- ARDS incidence is declining. Is it a preventable syndrome?
- Balanced crystalloids protect kidney better than saline
- Omalizumab helps asthma COPD overlap patients
- Nebulized glycopyrrolate improves lung function in COPD
- Nebulized LABA safe for long-term use in COPD
- IGRA preferred test for latent TB diagnosis
- Only half of appropriate COPD patients get long-acting bronchodilators
- Rapid influenza test obviates empiric antivirals
- Remimazolam surpasses midazolam
- Revised guidelines raise lung cancer screening age ceiling
- Ultrathin bronchoscopy plus radial EBUS unreliable at making diagnoses
- Phrenic-nerve stimulator maintains benefits for 18 months
- Cardiogenic shock boosts PAH readmissions 10-fold
- Evidence mounts for pulmonary embolism benefit from catheter thrombolysis
- Tracheobronchial tree size changes may predict IPF outcomes
- Shorter walk test predicts IPF outcomes
- Comparing arterial ratios may aid risk assessment in IPF
- FDA’s standards for approving generics are questioned
- Live Streaming at CHEST 2017
- Sepsis response team not beneficial
- Outcomes better for patients with H1N1 vaccination
- Lung recovery high after ECMO in near-fatal asthma
- Robotic-assisted pulmonary lobectomy removes large tumors
- Aspirin responsiveness improved in some with obstructive sleep apnea
- Solriamfetol improves excessive sleepiness in OSA patients
- Acute kidney injury linked with doubled inpatient VTEs
- Alarm reductions don’t improve ICU response times
- ARDS incidence is declining. Is it a preventable syndrome?
- Balanced crystalloids protect kidney better than saline
- Omalizumab helps asthma COPD overlap patients
- Nebulized glycopyrrolate improves lung function in COPD
- Nebulized LABA safe for long-term use in COPD
- IGRA preferred test for latent TB diagnosis
- Only half of appropriate COPD patients get long-acting bronchodilators
- Rapid influenza test obviates empiric antivirals
- Remimazolam surpasses midazolam
- Revised guidelines raise lung cancer screening age ceiling
- Ultrathin bronchoscopy plus radial EBUS unreliable at making diagnoses
- Phrenic-nerve stimulator maintains benefits for 18 months
- Cardiogenic shock boosts PAH readmissions 10-fold
- Evidence mounts for pulmonary embolism benefit from catheter thrombolysis
- Tracheobronchial tree size changes may predict IPF outcomes
- Shorter walk test predicts IPF outcomes
- Comparing arterial ratios may aid risk assessment in IPF
- FDA’s standards for approving generics are questioned
- Live Streaming at CHEST 2017
Publications
Publications
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Consolidated Pubs: Do Not Show Source Publication Logo
Use ProPublica